Outcomes Mandate National Integration With Cannabis as Medicine
Unknown statusPhase 2NCT03944447
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This will be a multistate, multicenter clinical study to determine the efficacy and safety of medical cannabis for a wide variety of chronic medical conditions.
Study details
- Official title
- Outcomes Mandate National Integration With Cannabis as Medicine
- Conditions
- Chronic Pain
- Chronic Pain Syndrome
- Chronic Pain Due to Injury
- Chronic Pain Due to Trauma
- Fibromyalgia
- Seizures
- Hepatitis C
- Cancer
- Crohn Disease
- Hiv/Aids
- Multiple Sclerosis
- Traumatic Brain Injury
- Sickle Cell Disease
- Post Traumatic Stress Disorder
- Tourette Syndrome
- Ulcerative Colitis
- Glaucoma
- Epilepsy
- Inflammatory Bowel Diseases
- Parkinson Disease
- Amyotrophic Lateral Sclerosis
- Chronic Traumatic Encephalopathy
- Anxiety
- Depression
- Insomnia
- Autism
- Opioid-use Disorder
- Bipolar Disorder
- Covid19
- SARS-CoV Infection
- Covid-19
- Corona Virus Infection
- Coronavirus
- Interventions
- Drug: Cannabis, Medical
- Device: RYAH-Medtech Inhaler
- Sponsor
- OMNI Medical Services, LLC
- Collaborators
- OMNI Medical Services Inc
- Start date
- 2018-12-01
- Primary completion
- 2025-12-31
- Sex
- All
- Age range
- from 7 Years
- Healthy volunteers
- true
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 17
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Clinical diagnosis of a Qualifying Condition for Medical Marijuana * Must be 18 years or older unless they have consent from their parent or legal guardian as defined under state law parameters * Must be willing to complete online surveys at baseline and the follow up points in this study Exclusion Criteria: * Pregnancy * Breastfeeding * Inability to provide informed consent * Inability to complete study visits or questionnaires * Active suicidality or psychosis, that could be exacerbated by the administration of cannabis
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03944447